Academician
EZGİ ÇOBAN
Doktor Öğretim Üyesi
Marmara Üniversitesi Tıp Fakültesi Dahili Tıp Bilimleri Bölümü
Research topics OpenAlex
- Breast Cancer Treatment Studies5
- HER2/EGFR in Cancer Research3
- COVID-19 and healthcare impacts1
- SARS-CoV-2 and COVID-19 Research1
- Cancer Diagnosis and Treatment1
- COVID-19 Clinical Research Studies1
- Advanced Breast Cancer Therapies1
- Cancer Treatment and Pharmacology1
- Genetic factors in colorectal cancer1
- Chemotherapy-induced cardiotoxicity and mitigation1
- Cell death mechanisms and regulation1
- Cardiovascular, Neuropeptides, and Oxidative Stress Research1
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Tıbbi Onkoloji (İç Hastalıkları)
Citation impact
OpenAlex YÖKSİS articles matched in OpenAlex: 8 + YÖKSİS · co-author record: 8
h-index
4
Percentile in Türkiye: 52
#876 of 2,222 at their university by h-index
- i10-index
- 2
- Total citations
- 78 Top 42% in Türkiye
- Per article
- 4.9
- FWCI
- 0.51 1.00 = world average
- World top 1%
- 0
- World top 10%
- 2
Most cited articles
- Efficacy and Safety Profile of COVID-19 Vaccine in Cancer Patients: A Prospective, Multicenter Cohort Study
- The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and endocrine therapy: A multicentric retrospective study
- Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients
How is this computed?
h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 8 articles (3 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list.
Field ranking
YÖKSİS ?-
Main field Sağlık Bilimleri Temel AlanıPoints rank #24,647/ 39,749 top 62.0% At university #474/ 667Score 6.1 journal 5.6 · OA add 0.5
- Article rank26,611/39,749
- Scopus rank22,986/39,749
- WoS rank22,719/39,749
- YÖKSİS8
- Scopus8
- WoS8
-
Side field Tıbbi Onkoloji (İç Hastalıkları)Points rank #238/ 284 top 83.8% At university #4/ 5Score 6.1 journal 5.6 · OA add 0.5
- Article rank243/284
- Scopus rank236/284
- WoS rank237/284
- YÖKSİS8
- Scopus8
- WoS8
Indexes and citation percentiles
?Top 1%0
Top 10%2
Avg · n 8
%58.2
Other counts
Scopus (SJR)
- YÖKSİS rows 8
WoS (JCR)
- YÖKSİS rows 8
Articles
Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.
Journals with publications
6 journals
Narrow down
Article list
- 2023 The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and endocrine therapy: A multicentric retrospective study YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 93.8%
- 2022 The Effect of FDG-PET/CT on Clinical Prognostic Staging of Breast Cancer Patients being Planned Neoadjuvant Treatment YÖKSİS SJR Q3 JCR Q4 OpenAlex 30.1%
- 2022 Efficacy and Safety Profile of COVID-19 Vaccine in Cancer Patients: A Prospective, Multicenter Cohort Study YÖKSİS SJR Q1 JCR Q3 OpenAlex top 10% OpenAlex 93.1%
- 2022 The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study YÖKSİS SJR Q3 JCR Q3 OpenAlex 53.8%
- 2022 Deficient Mismatch Repair and Lymphocytic Response to Tumor as Prognostic Markers in Stage II Colon Cancer Patients YÖKSİS SJR Q3 JCR Q4 OpenAlex 49.2%
- 2021 The Role of FDG PET/CT to Evaluation of Axillary Lymph Nodes after Neoadjuvant Chemotherapy in Breast Cancer YÖKSİS SJR Q4 JCR Q4 OpenAlex 36.7%
- 2020 Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer YÖKSİS SJR Q2 JCR Q3 OpenAlex 42.0%
- 2018 Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients YÖKSİS SJR Q3 JCR Q4 OpenAlex 67.1%